血清糖化白蛋白与内源性分泌型糖基化终产物受体比值对冠心病合并糖尿病患者冠状动脉支架内再狭窄评估(3)
[10]Di Pino A1， Urbano F1， Zagami RM1， et al. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes[J]. J Clin Endocrinol Metab，2016，101(4)：1701-1709.
[11]Vazzana N， Guagnano MT， Cuccurullo C， et al. Endogenous secretory RAGE in obese women： association with platelet activation and oxidative stress[J]. J Clin Endocrinol Metab，2012，97(9)：E1726-1730.
[12]Piarulli F1， Lapolla A， Ragazzi E， et al. Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients[J]. Atherosclerosis，2013，226(1)：252-257.
[13]Prasad K1， Tiwari S. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor-Mediated Cardiovascular Disease[J]. Curr Pharm Des，2017，23(6)：937-943.
[14]Lu L1， Pu LJ， Zhang Q， et al. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes[J]. Atherosclerosis，2009，206(2)：540-545.
[15]Shen Y， Pu LJ， Lu L， et al. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation[J]. Can J Cardiol，2012，28(6)：737-743.
(收稿日期：2018-7-27), 百拇医药(邬美翠 陆林 林祖近 蔡海鹏 陈磊)
[11]Vazzana N， Guagnano MT， Cuccurullo C， et al. Endogenous secretory RAGE in obese women： association with platelet activation and oxidative stress[J]. J Clin Endocrinol Metab，2012，97(9)：E1726-1730.
[12]Piarulli F1， Lapolla A， Ragazzi E， et al. Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients[J]. Atherosclerosis，2013，226(1)：252-257.
[13]Prasad K1， Tiwari S. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor-Mediated Cardiovascular Disease[J]. Curr Pharm Des，2017，23(6)：937-943.
[14]Lu L1， Pu LJ， Zhang Q， et al. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes[J]. Atherosclerosis，2009，206(2)：540-545.
[15]Shen Y， Pu LJ， Lu L， et al. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation[J]. Can J Cardiol，2012，28(6)：737-743.
(收稿日期：2018-7-27), 百拇医药(邬美翠 陆林 林祖近 蔡海鹏 陈磊)